Does Rallies track congressional trades in A?

Yes. Rallies tracks politician and congressional stock disclosures for A, including reported purchases, sales, dates, owners, and trade amounts when available.

Is A research on Rallies investment advice?

No. Rallies provides research, data, and educational context for A. It does not provide personalized investment advice.

A (Agilent Technologies Inc.) Stock Analysis - Politician Trades

Agilent Technologies Inc. (A) is a publicly traded Healthcare sector company. As of May 21, 2026, A trades at $113.83 with a market cap of $31.68B and a P/E ratio of 24.85. A moved +2.76% today. Year to date, A is -20.39%; over the trailing twelve months it is +0.26%. Its 52-week range spans $96.43 to $160.27. Analyst consensus is strong buy with an average price target of $158.62. Rallies surfaces A's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded A stock?

Recent politician trading activity in A includes disclosures from Lisa McClain, Lisa McClain, Rob Bresnahan, Jefferson Shreve, and Jefferson Shreve. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

A Key Metrics

Key financial metrics for A
Metric	Value
Price	$113.83
Market Cap	$31.68B
P/E Ratio	24.85
EPS	$4.55
Dividend Yield	0.26%
52-Week High	$160.27
52-Week Low	$96.43
Volume	0
Avg Volume	0
Revenue (TTM)	$7.07B
Net Income	$1.29B
Gross Margin	52.23%

Congressional Trades in A

Lisa McClain sale A on Jul 16, 2025 (amount: $15.00K) for Spouse.
Lisa McClain purchase A on Jun 17, 2025 (amount: $15.00K) for Spouse.
Rob Bresnahan purchase A on May 15, 2025 (amount: $15.00K).
Jefferson Shreve sale A on May 12, 2025 (amount: $50.00K).
Jefferson Shreve purchase A on Apr 17, 2025 (amount: $50.00K).

Latest A News

Agilent jumps as SEC filing confirms new chief legal officer ahead of Q2 results — May 5, 2026
Agilent Names 30-Year Legal Veteran Michael Buckner as Chief Legal Officer — May 4, 2026
Agilent jumps as traders reposition ahead of May 27 earnings after upbeat Q2 outlook — Apr 30, 2026
Agilent slides 3% as life-sciences tools weakness lingers into May 27 earnings — Apr 29, 2026
Agilent slides as life-sciences tools sector sours after Thermo Fisher Q1 update — Apr 23, 2026

Recent A Insider Trades

Dolsten Mikael sold 2.60K (~$389.51K) on Dec 1, 2025.
Gonsalves Rodney sold 3.00K (~$464.96K) on Nov 26, 2025.
MCDONNELL PADRAIG sold 911 (~$130.49K) on Nov 18, 2025.

A Analyst Consensus

13 analysts cover A: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $158.62.

Common questions about A

Which politicians traded A stock?: Recent politician trading activity in A includes disclosures from Lisa McClain, Lisa McClain, Rob Bresnahan, Jefferson Shreve, and Jefferson Shreve. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in A?: Yes. Rallies tracks politician and congressional stock disclosures for A, including reported purchases, sales, dates, owners, and trade amounts when available.
Is A research on Rallies investment advice?: No. Rallies provides research, data, and educational context for A. It does not provide personalized investment advice.